対デルタ ファイザー/アストラ 一発で３６％/30% ２発で８８％/67%

 

Wednesday's study found that two doses of Pfizer's shot was 88% effective at preventing symptomatic disease from the Delta variant, compared to 93.7% against the Alpha variant, broadly the same as previously reported.

Two shots of AstraZeneca vaccine were 67% effective against the Delta variant, up from 60% originally reported, and 74.5% effective against the Alpha variant, compared to an original estimate of 66% effectiveness.

The full study published on Wednesday found that one dose of Pfizer's shot was 36% effective, and one dose of AstraZeneca's vaccine was around 30% effective.

うん。いいね。 

更新

イスラエルでのpfizer/bioNtech2回接種後の有効率
対感染 39%
対発症 41%https://t.co/riMBiaaCQt　一方UKでは発症予防率は以前88％。この差はなんだろ？イスラエル株でも出現してるのか？

— Spica (@Kelangdbn) July 23, 2021